Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series

Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series

Idiopathic nephrotic syndrome (INS) represents 15%–30% of adulthood glomerulopathies. Corticosteroids have been the main treatment for decades and are effective in 70% of minimal-change disease patients and ~30% of focal segmental glomerulosclerosis patients. Multidrug-resistant (steroids, calcineur...

Full description

Bibliographic Details
Main Authors: Hamza Naciri Bennani, Thomas Jouve, Johan Noble, Lionel Rostaing, Paolo Malvezzi, Rachel Tetaz
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Case Reports in Nephrology
Online Access:http://dx.doi.org/10.1155/2019/7304786

Similar Items

Similar Items